• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Even ophthalmologists have difficulty spelling it sometimes

Article

Read the latest Optic Relief from OT cartoonist Jon Carter.

 

© Jon Carter 

Related Videos
EyeCon Co-chair Oluwatosin U. Smith, MD: Passion for Research and Education Drives Her Commitment to Ophthalmology
Video 3 - "Approaching Asymptomatic Cases with Risk Factors"
Video 2 - "Do Dry Eye Diagnostics Change the Management of Dry Eye?"
Elias Kahan, MD, speaks at the 2024 ARVO meeting
Andrew Pucker, OD, PhD
Related Content
Recurrent uveitis potential after COVID-19 vaccination in patients with a uveitis history

Recurrent uveitis potential after COVID-19 vaccination in patients with a uveitis history

Article
Claris Bio's journey toward treating neurotrophic keratitis

Claris Bio's journey toward treating neurotrophic keratitis

Podcast
Prior intravitreal injections may be associated with risk of postoperative cataract surgery complications

Prior intravitreal injections may be associated with risk of postoperative cataract surgery complications

Article
Ehsan Sadri, MD, leads an ophthalmology innovation discussion with Jeffry Weinhuff of Visionary Ventures

(EyePod) From idea to impact: Navigating ophthalmic innovation

Podcast
Research suggests tear fluid testing as promising method for Huntington’s Disease monitoring

Research suggests tear fluid testing as promising method for Huntington’s Disease monitoring

Article
Study finds tylectomy, paired with normal therapy, shows positive impact on eye survival in retinoblastoma patients

Study finds tylectomy, paired with normal therapy, shows positive impact on eye survival in retinoblastoma patients

Article
© 2024 MJH Life Sciences

All rights reserved.